Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis-Reference-Cited by-同舟云学术

Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis

Published:2022-10-26 Issue:5 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Grill Francisca J.¹,Jugler Collin¹²,Kaleta Erin³,Chen Qiang¹²,Magee D. Mitchell⁴,Grys Thomas E.³^ORCID,Lake Douglas F.¹^ORCID

Affiliation:

1. School of Life Sciences, Arizona State University, Tempe, Arizona, USA

2. Center for Immunotherapy, Vaccines and Virotherapy, Biodesign Institute, Arizona State University, Tempe, Arizona, USA

3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA

4. Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA

Abstract

In southwestern and western regions of the United States, at least half a million diagnostic tests for coccidioidomycosis (valley fever) are run annually. Enzyme immunoassays (EIAs) are blood tests which require precise dilution of patient serum prior to testing.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02573-22

Reference24 articles.

1. Coccidioidomycosis—A Fungal Disease of the Americas

2. Update on the Epidemiology of Coccidioidomycosis

3. Varieties of Coccidioidal Infection in Relation to the Epidemiology and Control of the Diseases

4. The immune response in Coccidioidomycosis

5. Laboratory Aspects in the Diagnosis of Coccidioidomycosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies;Journal of Clinical Microbiology;2023-09-21